Symbols / NGEN Stock $3.77 -2.84% NervGen Pharma Corp.
NGEN (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. The company's lead product candidate is NVG-291 that is in Phase 1b/2a clinical trial for the treatment of spinal cord injuries (SCI), stroke, multiple sclerosis, and Alzheimer's disease; and NVG-300, which is in a preclinical model of ischemic stroke and confirmatory SCI study. NervGen Pharma Corp. has a licensing agreement with Case Western Reserve University to develop and commercialize a patented technology with therapeutic potential for spinal cord injury and other conditions associated with nerve damage. The company was incorporated in 2017 and is based in Vancouver, Canada.
Ratings
Current target
$3.77
Low
$4.39
High
$18.00
Mean
$10.16
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-04-27 | init | HC Wainwright & Co. | — → Buy | $18 |
- symbol__ Stock Quote Price and Forecast - CNN Fri, 09 Jan 2026 23
- NGEN Initiated Coverage by HC Wainwright & Co. -- Price Target A - GuruFocus Mon, 27 Apr 2026 13
- NervGen Pharma (NGEN) 10K Form and Latest SEC Filings 2026 - MarketBeat ue, 28 Apr 2026 09
- FDA aligns on NervGen trial targeting hand use in tetraplegia - Stock Titan ue, 07 Apr 2026 07
- When Will NervGen Pharma Corp. (CVE:NGEN) Breakeven? - Yahoo Finance Sun, 01 Feb 2026 08
- NervGen Pharma Names New CFO and Wins Shareholder Backing for 2026 Equity Plan - TipRanks Mon, 27 Apr 2026 23
- NGEN Stock Price and Chart — NASDAQ:NGEN - TradingView hu, 08 Jan 2026 15
- NGEN.CA Stock Price, Quote & Chart | NERVGEN PHARMA CORP (TSX-V:NGEN) - ChartMill Mon, 16 Mar 2026 07
- NervGen Pharma: I See Promise, But The Clock Is Ticking (Rating Downgrade) (NASDAQ:NGEN) - Seeking Alpha ue, 17 Mar 2026 07
- This LB Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga Mon, 27 Apr 2026 12
- NervGen (NGEN) Stock: Why Short Sellers Target It (+1.19%) 2026-04-15 - Volume Breakout - Cổng thông tin điện tử Tỉnh Sơn La Wed, 15 Apr 2026 07
- NGEN Stock Analysis: NervGen Pharma Corp. Common stock gains 4.24% at 3.93 dollars - UBND thành phố Hải Phòng Wed, 01 Apr 2026 07
- Is NervGen Pharma (CVE:NGEN) In A Good Position To Invest In Growth? - Yahoo Finance ue, 11 Nov 2025 08
- NGEN Options Volatility — NASDAQ:NGEN - TradingView Sun, 12 Apr 2026 16
- NGEN Stock Price, News & Analysis - Stock Titan hu, 08 Jan 2026 11
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Revenue |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Operating Expense |
|
25.08
-0.38%
|
25.18
+41.62%
|
17.78
-22.79%
|
23.03
|
| Research And Development |
|
13.91
-12.04%
|
15.81
+96.50%
|
8.05
-51.57%
|
16.61
|
| Selling General And Administration |
|
11.17
+19.65%
|
9.34
-3.06%
|
9.63
+51.96%
|
6.34
|
| General And Administrative Expense |
|
11.17
+19.65%
|
9.34
-3.06%
|
9.63
+51.96%
|
6.34
|
| Salaries And Wages |
|
6.77
+1.17%
|
6.69
-1.11%
|
6.76
+106.42%
|
3.28
|
| Other Gand A |
|
4.41
+66.31%
|
2.65
-7.65%
|
2.87
-6.33%
|
3.06
|
| Total Expenses |
|
25.08
-0.38%
|
25.18
+41.62%
|
17.78
-22.79%
|
23.03
|
| Operating Income |
|
-25.08
+0.38%
|
-25.18
-41.62%
|
-17.78
+22.79%
|
-23.03
|
| EBITDA |
|
-25.02
+0.27%
|
-25.09
-42.31%
|
-17.63
+12.25%
|
-20.09
|
| Normalized EBITDA |
|
-5.65
+77.58%
|
-25.21
-102.03%
|
-12.48
+45.06%
|
-22.71
|
| Reconciled Depreciation |
|
0.06
-33.42%
|
0.08
-42.21%
|
0.15
+25.96%
|
0.12
|
| EBIT |
|
-25.08
+0.38%
|
-25.18
-41.62%
|
-17.78
+12.03%
|
-20.21
|
| Total Unusual Items |
|
-19.37
-17169.93%
|
0.11
+102.20%
|
-5.16
-297.08%
|
2.62
|
| Total Unusual Items Excluding Goodwill |
|
-19.37
-17169.93%
|
0.11
+102.20%
|
-5.16
-297.08%
|
2.62
|
| Net Income |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Pretax Income |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Net Non Operating Interest Income Expense |
|
0.33
-58.97%
|
0.81
+47.73%
|
0.55
+275.63%
|
-0.31
|
| Interest Expense Non Operating |
|
—
|
—
|
0.00
-100.00%
|
0.51
|
| Net Interest Income |
|
0.33
-58.97%
|
0.81
+47.73%
|
0.55
+275.63%
|
-0.31
|
| Interest Expense |
|
—
|
—
|
0.00
-100.00%
|
0.51
|
| Interest Income Non Operating |
|
0.33
-58.97%
|
0.81
+47.73%
|
0.55
+173.13%
|
0.20
|
| Interest Income |
|
0.33
-58.97%
|
0.81
+47.73%
|
0.55
+173.13%
|
0.20
|
| Other Income Expense |
|
-19.37
-17169.93%
|
0.11
+102.20%
|
-5.16
-297.08%
|
2.62
|
| Gain On Sale Of Security |
|
-19.37
-17169.93%
|
0.11
+102.20%
|
-5.16
-297.08%
|
2.62
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Net Income From Continuing Operation Net Minority Interest |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Net Income From Continuing And Discontinued Operation |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Net Income Continuous Operations |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Normalized Income |
|
-24.75
-1.57%
|
-24.36
-41.43%
|
-17.23
+26.19%
|
-23.34
|
| Net Income Common Stockholders |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Diluted EPS |
|
—
|
-0.36
+5.26%
|
-0.38
+2.56%
|
-0.39
|
| Basic EPS |
|
—
|
-0.36
+5.26%
|
-0.38
+2.56%
|
-0.39
|
| Basic Average Shares |
|
—
|
67.32
+13.55%
|
59.29
+12.61%
|
52.65
|
| Diluted Average Shares |
|
—
|
67.32
+13.55%
|
59.29
+12.61%
|
52.65
|
| Diluted NI Availto Com Stockholders |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Depreciation Amortization Depletion Income Statement |
|
0.00
-100.00%
|
0.03
-71.59%
|
0.10
+34.36%
|
0.07
|
| Depreciation And Amortization In Income Statement |
|
0.00
-100.00%
|
0.03
-71.59%
|
0.10
+34.36%
|
0.07
|
| Depreciation Income Statement |
|
0.00
-100.00%
|
0.03
-71.59%
|
0.10
+34.36%
|
0.07
|
| Total Other Finance Cost |
|
—
|
—
|
—
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
23.21
+19.11%
|
19.49
+47.22%
|
13.24
-44.56%
|
23.88
|
| Current Assets |
|
22.80
+19.92%
|
19.01
+51.91%
|
12.52
-45.93%
|
23.15
|
| Cash Cash Equivalents And Short Term Investments |
|
22.08
+27.14%
|
17.36
+48.93%
|
11.66
-48.07%
|
22.45
|
| Cash And Cash Equivalents |
|
22.07
+27.81%
|
17.27
+48.10%
|
11.66
-48.07%
|
22.45
|
| Cash Financial |
|
—
|
—
|
—
|
22.45
|
| Other Short Term Investments |
|
0.01
-91.39%
|
0.10
|
0.00
|
—
|
| Receivables |
|
0.08
-80.54%
|
0.42
+65.98%
|
0.25
+825.77%
|
0.03
|
| Accounts Receivable |
|
—
|
—
|
0.25
+825.77%
|
0.03
|
| Other Receivables |
|
0.03
-90.65%
|
0.27
+8.31%
|
0.25
|
—
|
| Taxes Receivable |
|
0.06
-61.63%
|
0.14
+43735.15%
|
0.00
|
—
|
| Prepaid Assets |
|
—
|
0.72
+21.64%
|
0.59
-12.02%
|
0.67
|
| Current Deferred Assets |
|
0.00
-100.00%
|
0.41
|
0.00
|
—
|
| Other Current Assets |
|
0.64
-22.00%
|
0.82
+4937.45%
|
0.02
|
—
|
| Total Non Current Assets |
|
0.41
-13.56%
|
0.47
-34.31%
|
0.72
-0.85%
|
0.73
|
| Net PPE |
|
0.00
|
0.00
-100.00%
|
0.20
-32.34%
|
0.30
|
| Gross PPE |
|
0.00
|
0.00
-100.00%
|
0.20
-32.34%
|
0.30
|
| Other Properties |
|
—
|
—
|
0.20
-32.34%
|
0.30
|
| Goodwill And Other Intangible Assets |
|
0.41
-12.00%
|
0.46
-10.71%
|
0.52
+20.71%
|
0.43
|
| Other Intangible Assets |
|
0.41
-12.00%
|
0.46
-10.71%
|
0.52
+20.71%
|
0.43
|
| Investments And Advances |
|
0.00
-100.00%
|
0.01
|
0.00
|
—
|
| Other Investments |
|
0.00
-100.00%
|
0.01
|
0.00
|
—
|
| Total Liabilities Net Minority Interest |
|
19.73
+16.70%
|
16.91
+10.92%
|
15.25
+46.39%
|
10.41
|
| Current Liabilities |
|
19.73
+16.75%
|
16.90
+11.64%
|
15.14
+48.18%
|
10.22
|
| Payables And Accrued Expenses |
|
3.29
-12.82%
|
3.78
+48.14%
|
2.55
-24.94%
|
3.40
|
| Payables |
|
0.03
-17.87%
|
0.03
-98.99%
|
3.32
+32.52%
|
2.51
|
| Accounts Payable |
|
—
|
—
|
3.32
+65.90%
|
2.00
|
| Other Payable |
|
0.03
-17.87%
|
0.03
|
—
|
—
|
| Current Accrued Expenses |
|
3.27
-12.77%
|
3.75
+46.83%
|
2.55
+185.92%
|
0.89
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
1.36
+17.24%
|
1.16
+63.65%
|
0.71
|
—
|
| Current Debt And Capital Lease Obligation |
|
0.01
-91.39%
|
0.10
+6.17%
|
0.09
+6.17%
|
0.09
|
| Current Capital Lease Obligation |
|
0.01
-91.39%
|
0.10
+6.17%
|
0.09
+6.17%
|
0.09
|
| Other Current Liabilities |
|
15.07
+27.01%
|
11.86
+0.64%
|
11.79
+75.08%
|
6.73
|
| Total Non Current Liabilities Net Minority Interest |
|
0.00
-100.00%
|
0.01
-92.08%
|
0.11
-46.45%
|
0.20
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
0.01
-92.08%
|
0.11
-46.45%
|
0.20
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
0.01
-92.08%
|
0.11
-46.45%
|
0.20
|
| Stockholders Equity |
|
3.48
+34.94%
|
2.58
+228.25%
|
-2.01
-114.93%
|
13.46
|
| Common Stock Equity |
|
3.48
+34.94%
|
2.58
+228.25%
|
-2.01
-114.93%
|
13.46
|
| Capital Stock |
|
103.00
+26.85%
|
81.19
+37.78%
|
58.93
+2.65%
|
57.41
|
| Common Stock |
|
103.00
+26.85%
|
81.19
+37.78%
|
58.93
+2.65%
|
57.41
|
| Share Issued |
|
79.21
+12.62%
|
70.33
+18.00%
|
59.61
+1.41%
|
58.78
|
| Ordinary Shares Number |
|
79.21
+12.62%
|
70.33
+18.00%
|
59.61
+1.41%
|
58.78
|
| Retained Earnings |
|
-146.76
-42.98%
|
-102.65
-31.34%
|
-78.15
-40.13%
|
-55.77
|
| Gains Losses Not Affecting Retained Earnings |
|
47.24
+96.61%
|
24.03
+39.60%
|
17.21
+45.62%
|
11.82
|
| Total Equity Gross Minority Interest |
|
3.48
+34.94%
|
2.58
+228.25%
|
-2.01
-114.93%
|
13.46
|
| Total Capitalization |
|
3.48
+34.94%
|
2.58
+228.25%
|
-2.01
-114.93%
|
13.46
|
| Working Capital |
|
3.07
+45.28%
|
2.11
+180.47%
|
-2.62
-120.29%
|
12.93
|
| Invested Capital |
|
3.48
+34.94%
|
2.58
+228.25%
|
-2.01
-114.93%
|
13.46
|
| Total Debt |
|
0.01
-92.08%
|
0.11
-46.45%
|
0.20
-30.43%
|
0.28
|
| Capital Lease Obligations |
|
0.01
-92.08%
|
0.11
-46.45%
|
0.20
-30.43%
|
0.28
|
| Net Tangible Assets |
|
3.07
+45.28%
|
2.11
+183.47%
|
-2.53
-119.42%
|
13.03
|
| Tangible Book Value |
|
3.07
+45.28%
|
2.11
+183.47%
|
-2.53
-119.42%
|
13.03
|
| Dueto Related Parties Current |
|
—
|
—
|
0.44
-13.04%
|
0.50
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-19.50
-15.78%
|
-16.84
-49.09%
|
-11.30
+36.49%
|
-17.78
|
| Cash Flow From Continuing Operating Activities |
|
-19.50
-15.78%
|
-16.84
-49.09%
|
-11.30
+36.49%
|
-17.78
|
| Net Income From Continuing Operations |
|
-44.12
-81.93%
|
-24.25
-8.35%
|
-22.38
-8.01%
|
-20.72
|
| Depreciation Amortization Depletion |
|
0.06
-33.42%
|
0.08
-42.21%
|
0.15
+25.96%
|
0.12
|
| Depreciation |
|
0.00
-100.00%
|
0.03
-71.59%
|
0.10
+34.36%
|
0.07
|
| Amortization Cash Flow |
|
0.06
+0.00%
|
0.06
+20.17%
|
0.05
+11.21%
|
0.04
|
| Depreciation And Amortization |
|
0.06
-33.42%
|
0.08
-42.21%
|
0.15
+25.96%
|
0.12
|
| Amortization Of Intangibles |
|
0.06
+0.00%
|
0.06
+20.17%
|
0.05
+11.21%
|
0.04
|
| Other Non Cash Items |
|
—
|
0.01
-33.22%
|
0.01
-97.23%
|
0.53
|
| Stock Based Compensation |
|
5.39
-10.68%
|
6.04
-0.08%
|
6.04
+117.83%
|
2.77
|
| Operating Gains Losses |
|
18.51
+4134.26%
|
0.44
-91.47%
|
5.12
+297.34%
|
-2.60
|
| Gain Loss On Investment Securities |
|
18.96
+13846.90%
|
0.14
-97.28%
|
4.99
+361.59%
|
-1.91
|
| Net Foreign Currency Exchange Gain Loss |
|
-0.45
-253.61%
|
0.29
+129.87%
|
0.13
+118.65%
|
-0.69
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.01
|
0.00
|
—
|
| Change In Working Capital |
|
0.66
-21.60%
|
0.84
+448.89%
|
-0.24
-111.36%
|
2.11
|
| Change In Receivables |
|
0.33
+302.60%
|
-0.17
+26.03%
|
-0.22
-703.60%
|
0.04
|
| Changes In Account Receivables |
|
—
|
-0.17
+26.03%
|
-0.22
-703.60%
|
0.04
|
| Change In Prepaid Assets |
|
0.59
+364.25%
|
-0.22
-490.31%
|
0.06
+123.65%
|
-0.24
|
| Change In Payables And Accrued Expense |
|
-0.27
-121.85%
|
1.23
+1747.76%
|
-0.07
-103.21%
|
2.32
|
| Change In Payable |
|
—
|
—
|
—
|
2.32
|
| Change In Account Payable |
|
—
|
—
|
—
|
2.32
|
| Investing Cash Flow |
|
0.10
+71.43%
|
0.06
+142.40%
|
-0.14
-557.92%
|
-0.02
|
| Cash Flow From Continuing Investing Activities |
|
0.10
+71.43%
|
0.06
+142.40%
|
-0.14
-557.92%
|
-0.02
|
| Net PPE Purchase And Sale |
|
—
|
0.00
+100.00%
|
-0.00
+85.43%
|
-0.02
|
| Purchase Of PPE |
|
—
|
0.00
+100.00%
|
-0.01
+73.36%
|
-0.02
|
| Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.00
|
0.00
|
| Capital Expenditure |
|
—
|
—
|
-0.14
-570.00%
|
-0.02
|
| Net Intangibles Purchase And Sale |
|
0.10
+71.43%
|
0.06
+143.36%
|
-0.14
|
0.00
|
| Purchase Of Intangibles |
|
—
|
0.00
+100.00%
|
-0.14
|
0.00
|
| Financing Cash Flow |
|
23.76
+4.71%
|
22.70
+2861.71%
|
0.77
-96.62%
|
22.64
|
| Cash Flow From Continuing Financing Activities |
|
23.76
+4.71%
|
22.70
+2861.71%
|
0.77
-96.62%
|
22.64
|
| Net Issuance Payments Of Debt |
|
-0.10
+0.00%
|
-0.10
+0.00%
|
-0.10
-33.33%
|
-0.08
|
| Repayment Of Debt |
|
-0.10
+0.00%
|
-0.10
+0.00%
|
-0.10
-33.33%
|
-0.08
|
| Long Term Debt Payments |
|
-0.10
+0.00%
|
-0.10
+0.00%
|
-0.10
-33.33%
|
-0.08
|
| Net Long Term Debt Issuance |
|
-0.10
+0.00%
|
-0.10
+0.00%
|
-0.10
-33.33%
|
-0.08
|
| Net Common Stock Issuance |
|
16.88
-26.63%
|
23.01
|
0.00
-100.00%
|
19.76
|
| Proceeds From Stock Option Exercised |
|
7.87
+456.56%
|
1.41
+63.12%
|
0.87
-71.87%
|
3.08
|
| Net Other Financing Charges |
|
-0.89
+45.24%
|
-1.63
|
—
|
-0.13
|
| Changes In Cash |
|
4.37
-26.17%
|
5.91
+155.43%
|
-10.67
-320.59%
|
4.84
|
| Effect Of Exchange Rate Changes |
|
0.44
+243.11%
|
-0.31
-146.19%
|
-0.12
-118.04%
|
0.69
|
| Beginning Cash Position |
|
17.27
+48.10%
|
11.66
-48.07%
|
22.45
+32.62%
|
16.93
|
| End Cash Position |
|
22.07
+27.81%
|
17.27
+48.10%
|
11.66
-48.07%
|
22.45
|
| Free Cash Flow |
|
-19.50
-15.78%
|
-16.84
-47.25%
|
-11.44
+35.77%
|
-17.81
|
| Interest Paid Supplemental Data |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Common Stock Issuance |
|
16.88
-26.63%
|
23.01
|
0.00
-100.00%
|
19.76
|
| Issuance Of Capital Stock |
|
16.88
-26.63%
|
23.01
|
0.00
-100.00%
|
19.76
|
| Sale Of Intangibles |
|
0.10
+71.43%
|
0.06
|
0.00
|
—
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|